Davids Introduces Bill Requiring Pharma Companies to Include Drug Prices in Ads

February 13, 2020
Press Release

Today, Representative Sharice Davids introduced the Transparency in Prescription Drug Advertising Act, which would require pharmaceutical companies to include the list prices of their prescription drugs in all direct-to-consumer (DTC) advertisements. This legislation holds pharmaceutical companies accountable for their prices, especially as the cost of prescription drugs continues to rise.

“Big pharmaceutical companies flood Kansans’ airwaves with ads for prescription drugs – but leave us in the dark about the price. My bill will hold pharmaceutical companies accountable to the public for their prices and help to halt the skyrocketing cost of prescription drugs, so Kansas families can finally have some relief,” said Davids. 

DTC pharmaceutical advertising in the U.S. is unparalleled in the rest of the world – the U.S. and New Zealand are the only two countries that even allow such advertising. The average American sees nine DTC prescription drug advertisements every day.

The American Medical Association – the largest association of physicians in the country – says DTC advertising “inflates demand for new and more expensive drugs, even when these drugs may not be appropriate.”

“Whether it’s a mom worrying about affording insulin for her children or a cancer patient fearing bankruptcy due the price of his life-saving medications, the number one issue Kansans talk to me about is the cost of health care and prescription drugs. Their message is clear: we need leaders in Washington who will stand up to big drug companies and work to lower the rising cost of prescription drugs. And that’s what this bill will help do,” said Davids.

To view the bill, click here.